Florida GLP-1 & Weight-Loss Compliance 2026: A Med Spa Guide

Florida has built a national reputation as a state where it is genuinely possible to own a medical aesthetics business without being a physician. For weight-loss medicine, that reputation is largely deserved: a GLP-1 program that requires an elaborate friendly-PC structure in California can be owned outright by an entrepreneur, an investor group, or a nurse in Florida. The drug is the same; the ownership rules are not.

This is the state-specific companion to our national GLP-1 med spa compliance guide. The federal picture — the end of the compounding shortage exemptions, the branded-product landscape, the good-faith-exam expectation — applies in Florida too, and we will not repeat all of it here. What this guide does is layer Florida's distinctive legal frame on top: the absence of a CPOM bar, the standard-of-care exam requirement, the out-of-state telehealth registration regime, APRN autonomous practice under HB 607, RN standing orders, and Florida's pharmacy-board overlay on sourcing.

And because the contrast is so instructive, we will set Florida directly against California — the subject of our California GLP-1 compliance guide — to show exactly what ownership freedom does and does not buy you.

Why Florida Is an Attractive State for GLP-1 Programs

Three features make Florida one of the easiest large markets in which to launch a compliant GLP-1 program — and they reinforce one another.

1. No Corporate Practice of Medicine Bar

Florida does not enforce a corporate practice of medicine doctrine. A non-physician can own the business entity that operates a med spa and can even employ physicians, provided the physician retains control of medical decision-making. That single fact removes the friendly-PC-plus-MSO scaffolding that dominates California planning and lets a Florida operator hold the business directly.

2. A Genuine Autonomous-Practice Lane for APRNs

Since HB 607 took effect in 2020, qualifying advanced practice registered nurses (APRNs) can register for autonomous practice and prescribe within primary-care scope without a supervising-physician protocol. Because medical weight management sits inside primary care, an autonomous APRN can run a GLP-1 program independently — a meaningful structural advantage.

3. A Deep, Year-Round Patient Market

Beyond the legal frame, Florida's population profile — large, growing, with high rates of obesity-related comorbidities and a strong cash-pay aesthetics culture — makes weight-loss demand durable. Compliance is the cost of entry, but the market rewards operators who get the structure right. For the broader state-by-state picture, see our national overview of GLP-1 med spa compliance.

Ownership: No Corporate Practice of Medicine Bar

The ownership question is where Florida and California diverge most sharply, so it is worth being precise about what Florida does and does not allow.

What Florida Permits

A layperson — an entrepreneur, an investor, a registered nurse, a multi-unit operator — may own the LLC or corporation that operates a Florida med spa and its GLP-1 program. There is no requirement that a physician hold equity in the operating company. This is the freedom that draws operators to Florida, and it is real.

The Line Florida Still Draws: Control, Not Ownership

Ownership is not the same as clinical control. A non-physician owner cannot make medical decisions, direct a prescriber's clinical judgment, or stand between the prescriber and the patient. The owner runs the business; a licensed clinician owns the medicine. In practice, that means the prescribing decisions, the exam, the treatment plan, the protocols, and chart review all sit with a physician or an appropriately licensed APRN or PA — never with the lay owner. A "nurse owns the spa, doctor signs for a flat fee and never engages" arrangement is exactly the kind of nominal oversight that invites a Board of Medicine problem.

The AHCA Health Care Clinic Wrinkle

Florida's Health Care Clinic Act requires many clinics with non-physician owners to obtain a Health Care Clinic license from the Agency for Health Care Administration (AHCA) if they bill third-party payers (insurance). Most med spa GLP-1 programs are cash-pay, which often places them in an exemption — but the analysis is fact-specific, and a licensed clinic must appoint a medical director under the Act. Confirm your licensure status with Florida counsel before you assume an exemption applies; we walk through registration versus exemption in the Florida NP med spa playbook.

The Exam Requirement Before Prescribing

Friendly ownership rules do not loosen the clinical standard. Before any GLP-1 prescription, Florida expects a real evaluation.

GLP-1s Are Legend Drugs, Not Controlled Substances

This distinction matters. Semaglutide, tirzepatide, and liraglutide are legend (prescription) drugs, not scheduled controlled substances. The strict controlled-substance physical-examination statute — the one that governs schedule II–IV prescribing for pain — does not apply to GLP-1s. What does apply is the general standard of care: a prescriber must establish a bona fide provider-patient relationship and evaluate the patient before prescribing.

Who Can Perform the Exam

The exam must be performed by a physician, an APRN (autonomous or supervised), or a physician assistant acting within scope. It cannot be delegated to a registered nurse, an LPN, or a medical assistant. This is the rule that trips up high-volume operations: a prescriber must actually evaluate the patient before an RN can administer anything.

What the Exam Should Document

For a GLP-1 program, the record should capture:

• Verified anthropometrics — measured height, weight, and BMI rather than a self-reported number when the patient can be weighed
• Medical and weight history — prior weight-loss attempts, current medications, allergies, relevant surgical history
• Comorbidities — type 2 diabetes, prediabetes, hypertension, dyslipidemia, sleep apnea, cardiovascular disease — which establish medical necessity
• Contraindication screen — personal or family history of medullary thyroid carcinoma (MTC), MEN-2, pancreatitis, gastroparesis, pregnancy or pregnancy planning, severe renal or hepatic impairment
• Informed consent — risks, benefits, common GI adverse events, serious risks, and off-label use where applicable
• Treatment plan — starting dose, titration schedule, monitoring, follow-up cadence, and discontinuation criteria

The full national documentation set lives in the complete GLP-1 guide. Florida's distinction is mostly in who may sign off and how the telehealth version of the exam is regulated.

Telehealth Prescribing Rules in Florida

Telehealth is central to modern weight-loss programs, and Florida is broadly permissive — within a registration framework that catches out-of-state prescribers.

Telehealth Is Allowed for GLP-1s

Florida law expressly permits establishing the provider-patient relationship and prescribing non-controlled drugs such as GLP-1s via telehealth. Because GLP-1 receptor agonists are not controlled substances, the in-person rules that govern controlled-substance teleprescribing do not bind a GLP-1 program. A Florida-licensed prescriber can perform the initial exam over a synchronous telehealth encounter and issue the prescription.

The Out-of-State Telehealth Provider Registration

Here is the Florida-specific catch. A prescriber who is not licensed in Florida but wants to treat Florida patients by telehealth must register with the Florida Department of Health as an out-of-state telehealth provider before doing so, and must carry professional liability coverage that meets Florida requirements. This matters for multi-state weight-loss platforms that route Florida patients to a national prescriber pool — every prescriber touching a Florida patient must be Florida-licensed or properly registered. The registration application and rules are published at flhealthsource.gov/telehealth.

The Standard of Care Does Not Drop

Telehealth changes the medium, not the requirement. A static online questionnaire that a clinician rubber-stamps is not an exam, and separate telehealth informed consent is expected. The synchronous good-faith encounter is the same regardless of drug formulation — a point we make for tablets too in the cluster post on oral GLP-1 options.

NP Autonomous Practice Under HB 607

Florida's autonomous-practice law is the feature that lets experienced nurse practitioners run a GLP-1 program without a supervising physician — and it is one of the clearest contrasts with most aesthetic procedures.

How an APRN Becomes Autonomous

Under HB 607 (2020), an APRN can register for autonomous practice after meeting the Board of Nursing's criteria. The core requirements are:

• A clear, active Florida APRN license
• At least 3,000 clinical hours supervised by an allopathic or osteopathic physician within the preceding five years (clinical hours earned during APRN education do not count)
• Graduate-level coursework in differential diagnosis and pharmacology within the last five years
• Professional liability coverage of at least $100,000 per claim / $300,000 aggregate

What Autonomous Practice Covers — and Where Weight Loss Fits

Autonomous primary-care practice in Florida is defined as family medicine, general pediatrics, and general internal medicine. Medical weight management with GLP-1s generally falls inside internal or family medicine, so a qualified autonomous APRN can typically perform the exam, prescribe, and run a GLP-1 weight-loss program independently — no physician protocol required.

The Aesthetic Carve-Out Operators Miss

The important caveat: autonomous practice is primary care. It does not extend to aesthetic procedures such as Botox, dermal filler, or laser. A med spa that pairs GLP-1 weight loss with injectables still needs physician delegation and supervision for the aesthetic side, even if the same APRN handles both. In other words, the GLP-1 program can run autonomously, but the Botox menu next to it cannot. We unpack that split in the Florida NP med spa playbook and the documentation requirements in our Florida medical director agreement guide. The Board of Nursing's autonomous-practice page is the authoritative source: floridasnursing.gov.

RN Administration and Standing Orders

Registered nurses are the workhorse of most GLP-1 injection programs, and Florida lets them do that work — under a prescriber's order and a written protocol.

What an RN Can Do

A Florida RN may administer a GLP-1 injection that has already been prescribed, perform follow-up weight and vitals checks, deliver patient education, and document the encounter. They act under a patient-specific order or a standing order / established protocol issued by the prescriber.

What a Standing Order Must Contain

A defensible standing order for a GLP-1 program should:

• Be issued and signed by the prescribing physician or APRN
• Name the specific drug(s), the patient population, and the circumstances under which the RN may administer
• Define the required training, experience, and ongoing competency for the administering nurse
• Tie administration to the prescriber's prior exam — the standing order authorizes administration, never the decision to prescribe

What an RN — and an MA — Cannot Do

An RN cannot perform the exam, diagnose, select the patient for treatment, or make the prescribing decision. A "standing order" that lets an RN approve weight-loss intakes without a prescriber's individualized exam is not a valid protocol — it is the unlicensed practice of medicine. And in Florida, medical assistants may not administer the GLP-1 injection; the same delegation logic that governs injectables applies here, as we detail in Florida Botox delegation documentation.

Physician and Medical-Director Roles in Florida

Even in a friendly ownership state, the physician role is rarely optional — and how it is structured determines whether your program survives scrutiny.

When a Medical Director Is Legally Required

Florida has no single statute that says "every med spa must name a medical director." But if the business holds an AHCA Health Care Clinic license — generally because it bills third-party payers — the Health Care Clinic Act requires a medical director who accepts statutory responsibilities. Cash-pay spas that qualify for an exemption avoid that specific mandate.

Why You Almost Always Want One Anyway

Mandate or not, unless the program is owned and run by an autonomous APRN prescribing within primary-care scope, a GLP-1 med spa needs a Florida-licensed physician to own the clinical program: approving the GLP-1 protocol and standing orders, supervising APRNs and PAs where supervision is required, signing off on consent forms, and conducting chart review. The physician's involvement must be genuine — a rented signature on a binder no one reads is the classic enforcement target. The agreement governing the role should be written and pay fair market value for actual services, never a percentage of medical revenue (fee-splitting). Compensation ranges and the FMV analysis are covered in our Florida medical director agreement guide.

Supervising PAs and Non-Autonomous APRNs

Where prescribers practice under supervision rather than autonomously, the supervising physician must maintain a valid protocol or practice agreement that includes weight-management prescribing, and must actually be reachable and engaged. Florida enforcement, like every state's, targets absentee supervision — a physician paid to be named but who never reviews a chart. The Florida Board of Medicine publishes practice standards at flboardofmedicine.gov.

GLP-1 Sourcing in Florida

Florida layers its own Board of Pharmacy oversight on top of the federal compounding picture, and the post-shortage landscape narrows the legal options considerably.

The Federal Baseline: The Compounding Era Ended

The FDA removed tirzepatide from its shortage list in October 2024 and semaglutide in February 2025. Once a drug leaves the shortage list, Section 503A pharmacies can no longer routinely compound copies of the FDA-approved product. The compounded-vial model that built thousands of weight-loss programs is no longer broadly legal. We cover the 503A versus 503B distinction in depth in the compounded GLP-1 sourcing guide.

What Florida Med Spas Should Source

The defensible options are the FDA-approved branded products: semaglutide (Wegovy for weight loss, Ozempic for diabetes) and tirzepatide (Zepbound for weight loss, Mounjaro for diabetes), plus liraglutide (Saxenda). These are dispensed by Florida-licensed pharmacies — or by out-of-state pharmacies holding a Florida nonresident pharmacy permit — on a valid prescription from a Florida-licensed (or registered) prescriber.

Florida's Pharmacy-Board Overlay

A Florida prescriber who keeps relying on compounded GLP-1 without a documented, patient-specific clinical need faces exposure on two fronts: the Board of Medicine (for prescribing outside the standard of care) and the Board of Pharmacy (which regulates compounding within the state and permits the nonresident pharmacies that ship in). Verify that any compounding partner is properly licensed and that any out-of-state mail-order partner holds a current Florida nonresident pharmacy permit before sending a single prescription. Sourcing also intersects with how long patients stay on therapy — a clinical and cost question we cover in the cluster post on GLP-1 maintenance and off-ramping.

Florida vs California: An Ownership Comparison

Setting the two states side by side is the fastest way to see what Florida's friendliness actually means — and where it stops.

Ownership: The Headline Difference

In California, the corporate practice of medicine doctrine bars lay ownership of the medical practice; investors operate through a friendly-PC-plus-MSO structure constrained by SB 351, or the practice must be owned by a physician or an independent "104" nurse practitioner. In Florida, a layperson can own the operating entity directly. That is the single largest structural saving Florida offers — no MSO, no friendly PC, no management services agreement to police.

What Is Actually the Same

Almost everything clinical. Both states require a real exam by a qualified prescriber before prescribing; both bar RNs from the prescribing decision while allowing them to administer; both treat telehealth as held to the in-person standard of care; and both sit on the same federal footing for compounding now that the shortages have ended. The freedom Florida grants is structural, not clinical.

The NP Lane, Compared

California's brand-new "104" NP can own and run an independent practice as of January 1, 2026; Florida's autonomous APRN has been able to practice primary care independently since 2020. Both are real lanes for weight-loss programs — but note the same boundary in each: independence covers primary-care weight management, not the aesthetic-injectables menu. The deeper California treatment is in our California GLP-1 compliance guide.

Building a Compliant Florida GLP-1 Program

Pulling the pieces together, here is the operational stack a Florida GLP-1 program should be able to produce on demand in 2026.

The Structural Layer

1. Ownership entity — a non-physician can own the operating company directly; confirm whether you need an AHCA Health Care Clinic license or qualify for a cash-pay exemption
2. Clinical control documentation — clear evidence that a physician or autonomous APRN, not the lay owner, controls medical decisions
3. Medical director agreement — written, FMV, no fee-splitting — unless the program runs under an autonomous APRN within primary-care scope

The Clinical Layer

1. Written GLP-1 protocol signed by the physician or autonomous APRN — eligibility, contraindications, titration, monitoring, discontinuation
2. Exam template performed only by a physician, APRN, or PA — never an RN or MA
3. RN standing orders — drug- and population-specific, tied to a prior exam, with training and competency defined
4. Informed consent (including off-label and boxed-warning disclosures) and separate telehealth consent
5. Contraindication screening checklist — MTC/MEN-2, pancreatitis, pregnancy, gastroparesis, renal/hepatic

The Operational Layer

1. Telehealth registration — every prescriber touching a Florida patient is Florida-licensed or registered as an out-of-state telehealth provider
2. Pharmacy documentation — Florida pharmacy permit or nonresident permit on file; no undocumented compounded sourcing
3. Follow-up workflow — recall at 4 weeks, then every 4–12 weeks during titration, with scheduled lab repeats
4. Supervision documentation — current protocols and practice agreements, chart-review logs for supervised prescribers
5. Adverse-event log — GI events, suspected pancreatitis, gallbladder events

For an at-a-glance view of every Florida-specific rule in one place, the Florida compliance hub collects all of our Florida guides. Industry organizations such as AmSpa publish Florida-focused legal updates worth tracking, and HB 607 (2020) is the primary source for the autonomous-practice rules above.

The Bottom Line for Florida Operators

Florida gives you something California does not: the freedom to own the business outright, without an MSO or a friendly PC. That is a genuine, money-saving advantage. But the clinical rules — the exam, scope of practice, telehealth registration, sourcing — are essentially as strict as anywhere, and Florida's enforcement environment for med spas has only intensified. The operators who win in Florida treat ownership freedom as a head start, not a free pass:

1. Own the operating entity directly, but keep medical decisions with a physician or autonomous APRN — never the lay owner
2. Confirm your AHCA Health Care Clinic licensure status rather than assuming an exemption
3. Keep the exam with a physician, APRN, or PA — never an RN or MA — and document it to the standard of care
4. Use valid, drug-specific standing orders for RN administration
5. Register every out-of-state telehealth prescriber and hold telehealth to the in-person standard
6. Source FDA-approved branded products through properly permitted pharmacies

Do those six things and you have a Florida GLP-1 program that can survive a Board of Medicine, Board of Nursing, AHCA, or Board of Pharmacy look — while keeping the ownership advantage that brought you to Florida in the first place.

Disclaimer: This article is for educational purposes only and does not constitute legal or medical advice. Florida's ownership, scope-of-practice, telehealth, and pharmacy rules are complex and change frequently. Verify current FDA shortage status and consult a Florida healthcare attorney and your medical director before establishing or modifying a weight-loss program.